{"id":339859,"date":"2025-08-19T19:10:38","date_gmt":"2025-08-19T19:10:38","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-transmedics\/"},"modified":"2025-08-19T19:10:38","modified_gmt":"2025-08-19T19:10:38","slug":"how-to-buy-transmedics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/","title":{"rendered":"How to buy TransMedics Group, Inc. (TMDX) shares &#8211; Investment in TransMedics Group, Inc. (TMDX) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-339859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy TransMedics Group, Inc. (TMDX) Shares - Investment in TransMedics Group, Inc. (TMDX) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy TransMedics Group, Inc. (TMDX) Shares - Investment in TransMedics Group, Inc. (TMDX) Stock"},"description":"Learn how to invest in TransMedics Group (TMDX) stock, current price $124.14, with expert analysis on risks, growth potential, and step-by-step buying process for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in TransMedics Group (TMDX) stock, current price $124.14, with expert analysis on risks, growth potential, and step-by-step buying process for 2025-2030."},"intro":"Thinking about investing in medical innovation that saves lives? TransMedics Group is revolutionizing organ transplantation with cutting-edge technology. This isn't just another biotech stock - it's a company literally giving people second chances at life while delivering impressive financial returns. Let's explore why TMDX deserves your attention and how you can become part of this life-changing journey.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in medical innovation that saves lives? TransMedics Group is revolutionizing organ transplantation with cutting-edge technology. This isn't just another biotech stock - it's a company literally giving people second chances at life while delivering impressive financial returns. Let's explore why TMDX deserves your attention and how you can become part of this life-changing journey."},"body_html":"<h2>\ud83d\udcc8 TransMedics Stock: Current Price and Critical Dates<\/h2> <p>As of August 19, 2025, TransMedics Group (TMDX) is trading at <strong>$124.14<\/strong> per share. But mark your calendar - <strong>October 27, 2025<\/strong> is the next major catalyst that could significantly move the stock price.<\/p> <p><strong>Why October 27 Matters:<\/strong><br> This is when TransMedics releases its Q3 2025 earnings report. Historically, their earnings announcements have created substantial price movements. Looking at recent history:<\/p> <ul> <li><strong>July 30, 2025<\/strong>: Q2 earnings beat expectations with $0.92 EPS vs $0.48 estimated - stock surged <strong>10.5%<\/strong> immediately after<\/li> <li><strong>April 29, 2025<\/strong>: Q1 results showed continued growth momentum - shares gained <strong>8.2%<\/strong> in the following week<\/li> <li><strong>January 28, 2025<\/strong>: Strong Q4 2024 results - stock climbed <strong>12.1%<\/strong> over two weeks<\/li> <\/ul> <p>The pattern is clear: TransMedics consistently beats estimates and the market rewards this performance handsomely. Each earnings report has triggered double-digit percentage moves, making these dates crucial for both entry and exit timing.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udd04 6-Month Price Journey: Rollercoaster with Rewards<\/h2> <p>TransMedics has taken investors on quite a ride over the past six months:<\/p> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Month<\/th> <th>Price Range<\/th> <th>Key Events<\/th> <\/tr> <\/thead> <tbody> <tr> <td>February 2025<\/td> <td>$85-95<\/td> <td>Post-holiday consolidation<\/td> <\/tr> <tr> <td>March 2025<\/td> <td>$98-112<\/td> <td>FDA approval rumors building<\/td> <\/tr> <tr> <td>April 2025<\/td> <td>$115-130<\/td> <td>Q1 earnings beat expectations<\/td> <\/tr> <tr> <td>May 2025<\/td> <td>$125-140<\/td> <td>Continued institutional buying<\/td> <\/tr> <tr> <td>June 2025<\/td> <td>$135-150<\/td> <td>Market-wide tech rally<\/td> <\/tr> <tr> <td>July 2025<\/td> <td>$145-160<\/td> <td>Q2 blowout earnings + FDA approval<\/td> <\/tr> <tr> <td>August 2025<\/td> <td>$120-130<\/td> <td>Profit-taking and consolidation<\/td> <\/tr> <\/tbody> <\/table> <p>The stock gained approximately <strong>46%<\/strong> over this six-month period, significantly outperforming the broader healthcare sector. This volatility isn't for the faint-hearted - TMDX moves with a beta of 2.08, meaning it's more than twice as volatile as the overall market.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Growth Trajectory<\/h2> <p>Based on current analyst projections and company guidance, here's what the future could hold:<\/p> <p><strong>2025 Year-End<\/strong>: $160-175 (29-41% upside from current levels)<br> <em>Rationale: Strong H2 performance, continued NOP program expansion<\/em><\/p> <p><strong>2026 Target<\/strong>: $190-210 (53-69% growth potential)<br> <em>Rationale: Full-year benefit of FDA approvals, international expansion<\/em><\/p> <p><strong>2028 Projection<\/strong>: $250-280 (101-126% total return)<br> <em>Rationale: $1 billion revenue target achievement, market dominance<\/em><\/p> <p><strong>2030 Vision<\/strong>: $300-350 (142-182% long-term appreciation)<br> <em>Rationale: Global adoption, new organ system developments<\/em><\/p> <p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The combination of technological leadership, expanding addressable market, and consistent execution makes TMDX a compelling growth story.<\/p>  <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider:<\/h3> <ul> <li><strong>High Valuation<\/strong>: Forward P\/E of 47.24 suggests premium pricing<\/li> <li><strong>Regulatory Dependency<\/strong>: FDA approvals crucial for continued growth<\/li> <li><strong>Market Concentration<\/strong>: 76% of revenue from liver transplants<\/li> <li><strong>Volatility<\/strong>: Beta of 2.08 means wild price swings<\/li> <li><strong>Profitability Timeline<\/strong>: Still burning cash for expansion<\/li> <\/ul> <h3>Green Lights for 2025:<\/h3> <ul> <li><strong>FDA Approval<\/strong>: Conditional IDE for Next-Gen OCS Lung trial granted<\/li> <li><strong>Revenue Guidance Raised<\/strong>: Now targeting $585-605 million for 2025<\/li> <li><strong>Market Expansion<\/strong>: Covering 79% of NOP missions requiring air transport<\/li> <li><strong>Industry Tailwinds<\/strong>: Organ transplant volume growing at 12% vs historical 3-4%<\/li> <li><strong>Technological Edge<\/strong>: Three FDA-approved systems with low penetration rates (4-18%)<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small<\/strong>: Begin with 1-2% portfolio allocation - this stock moves fast<\/li> <li><strong>Dollar-Cost Average<\/strong>: Buy in increments around earnings dates<\/li> <li><strong>Set Stop-Losses<\/strong>: At 15-20% below entry to manage volatility risk<\/li> <li><strong>Monitor FDA News<\/strong>: Regulatory approvals are major catalysts<\/li> <\/ol> <p>Humorous take: \"Trading TMDX is like being an organ transplant surgeon - steady hands during volatility save the patient (and your portfolio)!\"<\/p>  <h2>\u2705 How to Buy TransMedics Group, Inc. (TMDX) Shares - Step by Step<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Step<\/th> <th>Action<\/th> <th>Why It Matters<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Choose a Trading Platform<\/td> <td>Ensure it offers NASDAQ access and fractional shares<\/td> <\/tr> <tr> <td>2<\/td> <td>Complete Account Funding<\/td> <td>Start with manageable amount - even $100 works<\/td> <\/tr> <tr> <td>3<\/td> <td>Search \"TMDX\"<\/td> <td>Use the ticker symbol, not company name<\/td> <\/tr> <tr> <td>4<\/td> <td>Select Order Type<\/td> <td>Use limit orders around $120-125 for better entry<\/td> <\/tr> <tr> <td>5<\/td> <td>Review and Execute<\/td> <td>Check commission rates - aim for &lt;0.5%<\/td> <\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Fits New Medical Stock Investors<\/h2> <p>For those looking to invest in innovative companies like TransMedics, Pocket Option offers unique advantages:<\/p> <ul> <li><strong>Minimum deposit of just $5<\/strong> - Perfect for testing strategies with medical stocks that can be volatile<\/li> <li><strong>1-minute KYC verification<\/strong> - Upload any ID document and start trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong> - From crypto to e-wallets to traditional bank transfers<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for investors who want exposure to cutting-edge medical technology without committing large capital upfront.<\/p>  <h2>\ud83c\udf0d TransMedics in 2025: Revolutionizing Organ Transplantation<\/h2> <p>TransMedics isn't just another medical device company - it's fundamentally changing how organ transplants work. Their Organ Care System (OCS) technology keeps organs alive outside the body, dramatically increasing transplant success rates and expanding the donor pool.<\/p> <p>The company currently holds <strong>market leadership across all three organ categories<\/strong> (heart, liver, lung) and is responsible for nearly all the 20% growth in U.S. transplants over the past two years. With over 103,000 Americans on transplant waiting lists, the addressable market is enormous and growing.<\/p> <p><strong>Interesting Fact for 2025<\/strong>: TransMedics' new digital ecosystem, OCS NOP ACCESS, now connects major transplant programs across the U.S., creating what essentially functions as an \"Uber for organ transportation\" - matching available organs with recipients in real-time while ensuring perfect preservation conditions throughout the journey.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 TransMedics Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 19, 2025, TransMedics Group (TMDX) is trading at <strong>$124.14<\/strong> per share. But mark your calendar &#8211; <strong>October 27, 2025<\/strong> is the next major catalyst that could significantly move the stock price.<\/p>\n<p><strong>Why October 27 Matters:<\/strong><br \/> This is when TransMedics releases its Q3 2025 earnings report. Historically, their earnings announcements have created substantial price movements. Looking at recent history:<\/p>\n<ul>\n<li><strong>July 30, 2025<\/strong>: Q2 earnings beat expectations with $0.92 EPS vs $0.48 estimated &#8211; stock surged <strong>10.5%<\/strong> immediately after<\/li>\n<li><strong>April 29, 2025<\/strong>: Q1 results showed continued growth momentum &#8211; shares gained <strong>8.2%<\/strong> in the following week<\/li>\n<li><strong>January 28, 2025<\/strong>: Strong Q4 2024 results &#8211; stock climbed <strong>12.1%<\/strong> over two weeks<\/li>\n<\/ul>\n<p>The pattern is clear: TransMedics consistently beats estimates and the market rewards this performance handsomely. Each earnings report has triggered double-digit percentage moves, making these dates crucial for both entry and exit timing.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6-Month Price Journey: Rollercoaster with Rewards<\/h2>\n<p>TransMedics has taken investors on quite a ride over the past six months:<\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Month<\/th>\n<th>Price Range<\/th>\n<th>Key Events<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>February 2025<\/td>\n<td>$85-95<\/td>\n<td>Post-holiday consolidation<\/td>\n<\/tr>\n<tr>\n<td>March 2025<\/td>\n<td>$98-112<\/td>\n<td>FDA approval rumors building<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>$115-130<\/td>\n<td>Q1 earnings beat expectations<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>$125-140<\/td>\n<td>Continued institutional buying<\/td>\n<\/tr>\n<tr>\n<td>June 2025<\/td>\n<td>$135-150<\/td>\n<td>Market-wide tech rally<\/td>\n<\/tr>\n<tr>\n<td>July 2025<\/td>\n<td>$145-160<\/td>\n<td>Q2 blowout earnings + FDA approval<\/td>\n<\/tr>\n<tr>\n<td>August 2025<\/td>\n<td>$120-130<\/td>\n<td>Profit-taking and consolidation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock gained approximately <strong>46%<\/strong> over this six-month period, significantly outperforming the broader healthcare sector. This volatility isn&#8217;t for the faint-hearted &#8211; TMDX moves with a beta of 2.08, meaning it&#8217;s more than twice as volatile as the overall market.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Growth Trajectory<\/h2>\n<p>Based on current analyst projections and company guidance, here&#8217;s what the future could hold:<\/p>\n<p><strong>2025 Year-End<\/strong>: $160-175 (29-41% upside from current levels)<br \/> <em>Rationale: Strong H2 performance, continued NOP program expansion<\/em><\/p>\n<p><strong>2026 Target<\/strong>: $190-210 (53-69% growth potential)<br \/> <em>Rationale: Full-year benefit of FDA approvals, international expansion<\/em><\/p>\n<p><strong>2028 Projection<\/strong>: $250-280 (101-126% total return)<br \/> <em>Rationale: $1 billion revenue target achievement, market dominance<\/em><\/p>\n<p><strong>2030 Vision<\/strong>: $300-350 (142-182% long-term appreciation)<br \/> <em>Rationale: Global adoption, new organ system developments<\/em><\/p>\n<p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The combination of technological leadership, expanding addressable market, and consistent execution makes TMDX a compelling growth story.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider:<\/h3>\n<ul>\n<li><strong>High Valuation<\/strong>: Forward P\/E of 47.24 suggests premium pricing<\/li>\n<li><strong>Regulatory Dependency<\/strong>: FDA approvals crucial for continued growth<\/li>\n<li><strong>Market Concentration<\/strong>: 76% of revenue from liver transplants<\/li>\n<li><strong>Volatility<\/strong>: Beta of 2.08 means wild price swings<\/li>\n<li><strong>Profitability Timeline<\/strong>: Still burning cash for expansion<\/li>\n<\/ul>\n<h3>Green Lights for 2025:<\/h3>\n<ul>\n<li><strong>FDA Approval<\/strong>: Conditional IDE for Next-Gen OCS Lung trial granted<\/li>\n<li><strong>Revenue Guidance Raised<\/strong>: Now targeting $585-605 million for 2025<\/li>\n<li><strong>Market Expansion<\/strong>: Covering 79% of NOP missions requiring air transport<\/li>\n<li><strong>Industry Tailwinds<\/strong>: Organ transplant volume growing at 12% vs historical 3-4%<\/li>\n<li><strong>Technological Edge<\/strong>: Three FDA-approved systems with low penetration rates (4-18%)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Begin with 1-2% portfolio allocation &#8211; this stock moves fast<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Buy in increments around earnings dates<\/li>\n<li><strong>Set Stop-Losses<\/strong>: At 15-20% below entry to manage volatility risk<\/li>\n<li><strong>Monitor FDA News<\/strong>: Regulatory approvals are major catalysts<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading TMDX is like being an organ transplant surgeon &#8211; steady hands during volatility save the patient (and your portfolio)!&#8221;<\/p>\n<h2>\u2705 How to Buy TransMedics Group, Inc. (TMDX) Shares &#8211; Step by Step<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NASDAQ access and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Funding<\/td>\n<td>Start with manageable amount &#8211; even $100 works<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;TMDX&#8221;<\/td>\n<td>Use the ticker symbol, not company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders around $120-125 for better entry<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and Execute<\/td>\n<td>Check commission rates &#8211; aim for &lt;0.5%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Medical Stock Investors<\/h2>\n<p>For those looking to invest in innovative companies like TransMedics, Pocket Option offers unique advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit of just $5<\/strong> &#8211; Perfect for testing strategies with medical stocks that can be volatile<\/li>\n<li><strong>1-minute KYC verification<\/strong> &#8211; Upload any ID document and start trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; From crypto to e-wallets to traditional bank transfers<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for investors who want exposure to cutting-edge medical technology without committing large capital upfront.<\/p>\n<h2>\ud83c\udf0d TransMedics in 2025: Revolutionizing Organ Transplantation<\/h2>\n<p>TransMedics isn&#8217;t just another medical device company &#8211; it&#8217;s fundamentally changing how organ transplants work. Their Organ Care System (OCS) technology keeps organs alive outside the body, dramatically increasing transplant success rates and expanding the donor pool.<\/p>\n<p>The company currently holds <strong>market leadership across all three organ categories<\/strong> (heart, liver, lung) and is responsible for nearly all the 20% growth in U.S. transplants over the past two years. With over 103,000 Americans on transplant waiting lists, the addressable market is enormous and growing.<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: TransMedics&#8217; new digital ecosystem, OCS NOP ACCESS, now connects major transplant programs across the U.S., creating what essentially functions as an &#8220;Uber for organ transportation&#8221; &#8211; matching available organs with recipients in real-time while ensuring perfect preservation conditions throughout the journey.<\/p>\n"},"faq":[{"question":"Is TransMedics profitable yet?","answer":"Not currently - they're reinvesting heavily in growth and expansion, which is common for medical technology companies at this stage. Their gross margins of 59.5% show strong underlying economics."},{"question":"What's the biggest risk with TMDX stock?","answer":"Regulatory risk - FDA approvals can make or break medical device companies. However, they already have three approved systems and recently received conditional IDE approval for their next-generation lung system."},{"question":"How much of their revenue comes from liver transplants?","answer":"Approximately 76% currently, which represents both a concentration risk and massive growth opportunity as they expand heart and lung applications."},{"question":"What's the long-term growth potential?","answer":"Management targets $1 billion in revenue by 2028, representing a 28.5% compound annual growth rate from current levels."},{"question":"Should I wait for a pullback to buy?","answer":"Given the stock's volatility, pullbacks to the $115-120 range have historically provided good entry points. However, trying to time perfection often means missing the opportunity entirely."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is TransMedics profitable yet?","answer":"Not currently - they're reinvesting heavily in growth and expansion, which is common for medical technology companies at this stage. Their gross margins of 59.5% show strong underlying economics."},{"question":"What's the biggest risk with TMDX stock?","answer":"Regulatory risk - FDA approvals can make or break medical device companies. However, they already have three approved systems and recently received conditional IDE approval for their next-generation lung system."},{"question":"How much of their revenue comes from liver transplants?","answer":"Approximately 76% currently, which represents both a concentration risk and massive growth opportunity as they expand heart and lung applications."},{"question":"What's the long-term growth potential?","answer":"Management targets $1 billion in revenue by 2028, representing a 28.5% compound annual growth rate from current levels."},{"question":"Should I wait for a pullback to buy?","answer":"Given the stock's volatility, pullbacks to the $115-120 range have historically provided good entry points. However, trying to time perfection often means missing the opportunity entirely."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy TransMedics Group, Inc. (TMDX) shares - Investment in TransMedics Group, Inc. (TMDX) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy TransMedics Group, Inc. (TMDX) shares - Investment in TransMedics Group, Inc. (TMDX) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T19:10:38+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy TransMedics Group, Inc. (TMDX) shares &#8211; Investment in TransMedics Group, Inc. (TMDX) stock\",\"datePublished\":\"2025-08-19T19:10:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\",\"name\":\"How to buy TransMedics Group, Inc. (TMDX) shares - Investment in TransMedics Group, Inc. (TMDX) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-19T19:10:38+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy TransMedics Group, Inc. (TMDX) shares &#8211; Investment in TransMedics Group, Inc. (TMDX) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy TransMedics Group, Inc. (TMDX) shares - Investment in TransMedics Group, Inc. (TMDX) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/","og_locale":"en_US","og_type":"article","og_title":"How to buy TransMedics Group, Inc. (TMDX) shares - Investment in TransMedics Group, Inc. (TMDX) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T19:10:38+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy TransMedics Group, Inc. (TMDX) shares &#8211; Investment in TransMedics Group, Inc. (TMDX) stock","datePublished":"2025-08-19T19:10:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/","name":"How to buy TransMedics Group, Inc. (TMDX) shares - Investment in TransMedics Group, Inc. (TMDX) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-19T19:10:38+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy TransMedics Group, Inc. (TMDX) shares &#8211; Investment in TransMedics Group, Inc. (TMDX) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":339879,"slug":"how-to-buy-transmedics","post_title":"Comment acheter des actions de TransMedics Group, Inc. (TMDX) - Investissement dans les actions de TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-transmedics\/"},"it_IT":{"locale":"it_IT","id":339877,"slug":"how-to-buy-transmedics","post_title":"Come acquistare azioni TransMedics Group, Inc. (TMDX) - Investimento in azioni TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-transmedics\/"},"pl_PL":{"locale":"pl_PL","id":339878,"slug":"how-to-buy-transmedics","post_title":"Jak kupi\u0107 akcje TransMedics Group, Inc. (TMDX) - Inwestycja w akcje TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-transmedics\/"},"es_ES":{"locale":"es_ES","id":339883,"slug":"how-to-buy-transmedics","post_title":"C\u00f3mo comprar acciones de TransMedics Group, Inc. (TMDX) - Inversi\u00f3n en acciones de TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-transmedics\/"},"th_TH":{"locale":"th_TH","id":339882,"slug":"how-to-buy-transmedics","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 TransMedics Group, Inc. (TMDX) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-transmedics\/"},"tr_TR":{"locale":"tr_TR","id":339876,"slug":"how-to-buy-transmedics","post_title":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/"},"vt_VT":{"locale":"vt_VT","id":339881,"slug":"how-to-buy-transmedics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu TransMedics Group, Inc. (TMDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-transmedics\/"},"pt_AA":{"locale":"pt_AA","id":339880,"slug":"how-to-buy-transmedics","post_title":"Como comprar a\u00e7\u00f5es da TransMedics Group, Inc. (TMDX) - Investimento em a\u00e7\u00f5es da TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-transmedics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/339859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=339859"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/339859\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=339859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=339859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=339859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}